Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?

Affiliations

Editorial

Chang Soo Eun et al. Gut Liver. 2015.

. 2015 Sep 23;9(5):567-8.

doi: 10.5009/gnl15293.

¹ Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

No abstract available

Comment on

Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study.
Kim EH, Kim DH, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Kim EH, et al. Gut Liver. 2015 Sep 23;9(5):601-6. doi: 10.5009/gnl14120. Gut Liver. 2015. PMID: 25473080 Free PMC article.

1. Park SC, Jeen YT. Current and emerging biologics for ulcerative colitis. Gut Liver. 2015;9:18–27. doi: 10.5009/gnl14226. - DOI - PMC - PubMed
1. Seo HI, Park DI, Kim TO, et al. The effect of infliximab on patients with ulcerative colitis in Korea. Intest Res. 2014;12:214–220. doi: 10.5217/ir.2014.12.3.214. - DOI - PMC - PubMed
1. Sjöberg M, Walch A, Meshkat M, et al. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis. 2012;18:212–218. doi: 10.1002/ibd.21680. - DOI - PubMed
1. Croft A, Walsh A, Doecke J, Cooley R, Howlett M, Radford-Smith G. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab. Aliment Pharmacol Ther. 2013;38:294–302. doi: 10.1111/apt.12375. - DOI - PubMed
1. Chang KH, Burke JP, Coffey JC. Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis. Int J Colorectal Dis. 2013;28:287–293. doi: 10.1007/s00384-012-1602-8. - DOI - PubMed